Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAMA study of pertussis immunization during pregnancy
2020-003466-39Phase 4Completed
- Sponsor
- University of Antwerp
- Start
- Jul 2021
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of acellular pertussis vaccine, Hexyon and diphtheria and tetanus toxoids and acellular pertussis-inactivated poliovirus vaccine in pertussis (4 arms), sponsored by University of Antwerp. Primary endpoint: Difference in humoral immune response before and after infant vaccination. Started Jul 2021; status: completed.
02
Drugs
acellular pertussis vaccineHexyondiphtheria and tetanus toxoids and acellular pertussis-inactivated poliovirus vaccine
03
Conditions
pertussis
Beyond the preview
Go deeper on 2020-003466-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003466-39.